Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanwen Wu
Observed name:
Wu, Hanwen
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
First Affiliated Hospital of Wenzhou Medical University,
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0009-0008-1765-8702
Observed ORCID:
0009-0008-1765-8702
OpenAlex ID:
A5000011264
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
2025
·
Hanwen Wu
, Jiling Zhu
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
·
25
Efficacy of Dupilumab in Children 6 Months to 11 Years Old with Atopic Dermatitis: A Retrospective Real-World Study in China
2023
·
Nali Yang
, Yahui Ye
, et al.
·
Dermatitis
·
23
Three‐dimensional spheroid formation of adipose‐derived stem cells improves the survival of fat transplantation by enhance their therapeutic effect
2023
·
Yucang He
, Zikai Zhang
, et al.
·
Biotechnology Journal
·
10
PDF
Exazerbation der atopischen Dermatitis nach Behandlungsabbruch und prädiktive Faktoren für die Exazerbation: JAK1‐Inhibitoren versus Dupilumab
2025
·
Hanwen Wu
, Jiling Zhu
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Show more works
View as search
Works count:
6
Citation count:
58
H-index:
3
I10-index:
3
Year
Topic
Type